These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30213832)

  • 1. Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor.
    Biondi A; Cario G; De Lorenzo P; Castor A; Conter V; Leoni V; Gandemer V; Pieters R; Stary J; Escherich G; Campbell M; Attarbaschi A; Li CK; Vora A; Bradtke J; Saha V; Valsecchi MG; Schrappe M
    Haematologica; 2019 Jan; 104(1):e13-e16. PubMed ID: 30213832
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
    Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Imatinib Dosing With High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients With Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia.
    Pommert L; Liberio N; Ng JS; Egelund TA; Siver MJ; Katzenstein HM; Burke MJ
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e296-e300. PubMed ID: 32398599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
    Shen S; Chen X; Cai J; Yu J; Gao J; Hu S; Zhai X; Liang C; Ju X; Jiang H; Jin R; Wu X; Wang N; Tian X; Pan K; Jiang H; Sun L; Fang Y; Li CK; Hu Q; Yang M; Zhu Y; Zhang H; Li C; Pei D; Jeha S; Yang JJ; Cheng C; Tang J; Zhu X; Pui CH
    JAMA Oncol; 2020 Mar; 6(3):358-366. PubMed ID: 31944221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Jeha S; Coustan-Smith E; Pei D; Sandlund JT; Rubnitz JE; Howard SC; Inaba H; Bhojwani D; Metzger ML; Cheng C; Choi JK; Jacobsen J; Shurtleff SA; Raimondi S; Ribeiro RC; Pui CH; Campana D
    Cancer; 2014 May; 120(10):1514-9. PubMed ID: 24501014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.
    Chen H; Liu KY; Xu LP; Chen YH; Zhang XH; Wang Y; Qin YZ; Liu YR; Lai YY; Huang XJ
    Leuk Res; 2017 Aug; 59():136-141. PubMed ID: 28654842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
    Schultz KR; Bowman WP; Aledo A; Slayton WB; Sather H; Devidas M; Wang C; Davies SM; Gaynon PS; Trigg M; Rutledge R; Burden L; Jorstad D; Carroll A; Heerema NA; Winick N; Borowitz MJ; Hunger SP; Carroll WL; Camitta B
    J Clin Oncol; 2009 Nov; 27(31):5175-81. PubMed ID: 19805687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.
    Biondi A; Gandemer V; De Lorenzo P; Cario G; Campbell M; Castor A; Pieters R; Baruchel A; Vora A; Leoni V; Stary J; Escherich G; Li CK; Cazzaniga G; Cavé H; Bradtke J; Conter V; Saha V; Schrappe M; Grazia Valsecchi M
    Lancet Haematol; 2018 Dec; 5(12):e641-e652. PubMed ID: 30501871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.
    Schultz KR; Carroll A; Heerema NA; Bowman WP; Aledo A; Slayton WB; Sather H; Devidas M; Zheng HW; Davies SM; Gaynon PS; Trigg M; Rutledge R; Jorstad D; Winick N; Borowitz MJ; Hunger SP; Carroll WL; Camitta B;
    Leukemia; 2014 Jul; 28(7):1467-71. PubMed ID: 24441288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
    J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Daver N; Thomas D; Ravandi F; Cortes J; Garris R; Jabbour E; Garcia-Manero G; Borthakur G; Kadia T; Rytting M; Konopleva M; Kantarjian H; O'Brien S
    Haematologica; 2015 May; 100(5):653-61. PubMed ID: 25682595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe and Effective Use of Imatinib to Treat Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pregnancy.
    Ashraf S; Wolfson J; Vachhani P; Rangaraju S; Bachiashvili K; Bhatia R; Jamy O
    J Adolesc Young Adult Oncol; 2022 Dec; 11(6):617-620. PubMed ID: 35049365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Salami K; Alkayed K; Halalsheh H; Hussein AA; Riziq M; Madanat F
    Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):34-41. PubMed ID: 23664604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
    Uckun FM; Nachman JB; Sather HN; Sensel MG; Kraft P; Steinherz PG; Lange B; Hutchinson R; Reaman GH; Gaynon PS; Heerema NA
    Leuk Lymphoma; 1999 Mar; 33(1-2):101-6. PubMed ID: 10194126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JSH practical guidelines for hematological malignancies, 2018: I. leukemia-3. acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).
    Hatta Y; Hayakawa F; Yamazaki E
    Int J Hematol; 2020 Oct; 112(4):439-458. PubMed ID: 32812190
    [No Abstract]   [Full Text] [Related]  

  • 17. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
    Short NJ; Kantarjian HM; Sasaki K; Ravandi F; Ko H; Cameron Yin C; Garcia-Manero G; Cortes JE; Garris R; O'Brien SM; Patel K; Khouri M; Thomas D; Jain N; Kadia TM; Daver NG; Benton CB; Issa GC; Konopleva M; Jabbour E
    Am J Hematol; 2017 Mar; 92(3):238-243. PubMed ID: 28006851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographics and Outcome of Philadelphia-positive ALL in a Pediatric Population in North India: a Single-center Experience.
    Pant G; Kumar A; Verma N; Pooniya V; Sharma A; Gupta B
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):376-381. PubMed ID: 31033785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute lymphoblastic leukemia with Philadelphia chromosome: eight case reports].
    Laatiri MA; Chehata S; Amouri A; Sendi HS; Saad A; Ennabli S
    Tunis Med; 2001 Jan; 79(1):38-41. PubMed ID: 11332342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
    Gandemer V; Auclerc MF; Perel Y; Vannier JP; Le Gall E; Demeocq F; Schmitt C; Piguet C; Stephan JL; Lejars O; Debre M; Jonveaux P; Cayuela JM; Chevret S; Leverger G; Baruchel A;
    BMC Cancer; 2009 Jan; 9():14. PubMed ID: 19144139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.